BMR.H Bradmer Pharmaceuticals

Bradmer Pharmaceuticals Inc. (TSX VENTURE:BMR.H) announced today that it has
granted, subject to regulatory approval, options to directors and officers of
the company exercisable to acquire an aggregate of 1,500,000 common shares, at a
price of $0.10 per share, expiring July 21, 2021.

Bradmer Pharmaceuticals (TSXV:BMR.H)
過去 株価チャート
から 5 2024 まで 6 2024

Bradmer Pharmaceuticals (TSXV:BMR.H)
過去 株価チャート
から 6 2023 まで 6 2024